Decision Resources, Inc., May 2010, Pages: 23
Technologies and drugs for hard-to-treat infections are emerging as a trend in venture-backed investments. Historically, interest in biomarker and diagnostics development for infectious diseases
Greystone Associates, Aug 2011
demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2015.
Highlights
- Analyzes
Greystone Associates, May 2011
Microneedle technology is an enabling technology base for the development of needles with micro scale cross sectional dimensions and added functionality. The microneedles can be used
Frost & Sullivan, Oct 1997
, such as Evans Medical, Swiss Serum, and Procter & Gamble.
- Executive Summary
- The Growing Importance of the European Antiviral Drugs and Vaccines Market
- Major Market Trends
- Major Technology
Greystone Associates, March 2009, Pages: 180
, technologies, therapies, and potential for skin patches, and to identify business opportunities for skin patch products within the healthcare industry. Provider organization business managers, healthcare
Decision Resources, Inc., June 2011
of this market, and what is its growth trend? Which companies are the leaders based on 2010 sales? Will those rankings change? What opportunities are available to these and other contenders in the vaccines space?
- Pfizer
Business Insights, March 2011, Pages: 128
Biocatalysis in pharmaceutical manufacturing is being driven by advances in enzyme and genomics technologies that are increasing the breadth of reaction applicability. The environmental benefits
Venture Planning Group, Nov 2011, Pages: 800
critical than underlying technology. The changes in the marketplace, however, will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen
Business Insights, June 2009, Pages: 134
Solutions Innovations in In-Vitro Diagnostics - New Technologies, Growth Opportunities, and the Future Market Outlook
Venture Planning Group, April 2010, Pages: 460
, demographic, social and technologicaltrends with significant market impact during the next ten years. Specifically, the study explores the impact of anticipated changes in government regulations, trends
GlobalData, July 2010, Pages: 27
operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted
Venture Planning Group, April 2010, Pages: 410
, regulatory, demographic, social and technologicaltrends with significant market impact during the next ten years.
Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious
Venture Planning Group, April 2010, Pages: 420
, regulatory, demographic, social and technologicaltrends with significant market impact during the next ten years.
Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious
Venture Planning Group, April 2010, Pages: 410
, regulatory, demographic, social and technologicaltrends with significant market impact during the next ten years.
Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious
